Preclinical studies using a new treatment modality called FLASH Radiotherapy (FLASH-RT) need a two-phase procedure to ensure minimal uncertainties in the delivered dose. The first phase requires a new investigation of the reference dosimetry lying outside the conventional metrology framework from national metrology institutes but necessary to obtain traceability, repeatability, and stability of irradiations. The second consists of performing special quality assurance procedure prior to irradiation. The Oriatron eRT6 (PMB-Alcen, France) is an experimental high dose-per-pulse linear accelerator, delivering a 6 MeV pulsed electron beam with mean dose-rates, ranging from a few Gy/min up to thousands of Gy/s. Absolute dosimetry is investigated w...
High dose-rate radiotherapy, known as FLASH, has been shown to increase the differential response be...
High dose-rate radiotherapy, known as FLASH, has been shown to increase the differential response be...
As radiotherapy using ultra-high dose rates has gained new interest, the dosimetric challenges arisi...
We describe a multicenter cross validation of ultra-high dose rate (UHDR) (>= 40 Gy/s) irradiatio...
The Oriatron eRT6 is an experimental high dose-per-pulse linear accelerator (linac) which was design...
International audienceMost anticancer radiation therapy facilities are based on linear electron acce...
Purpose: The electron linac ElectronFlash installed at Institut Curie (Orsay, France) is entirely de...
FLASH radiation therapy (FLASH-RT), delivered with ultrahigh dose rate (UHDR), may allow patients to...
We describe a multicenter cross validation of ultra-high dose rate (UHDR) (>= 40 Gy/s) irradiatio...
We have performed dosimetry studies using electron beams with energies up to 50 MeV, which exceed cu...
FLASH radiation therapy (FLASH-RT) reference dosimetry to obtain traceability, repeatability and sta...
We have performed dosimetry studies using electron beams with energies up to 50 MeV, which exceed cu...
We have performed dosimetry studies using electron beams with energies up to 50 MeV, which exceed cu...
Abstract Purpose: The Oriatron eRT6 is a linear accelerator (linac) used in FLASH preclinical studie...
Abstract Purpose: The Oriatron eRT6 is a linear accelerator (linac) used in FLASH preclinical studie...
High dose-rate radiotherapy, known as FLASH, has been shown to increase the differential response be...
High dose-rate radiotherapy, known as FLASH, has been shown to increase the differential response be...
As radiotherapy using ultra-high dose rates has gained new interest, the dosimetric challenges arisi...
We describe a multicenter cross validation of ultra-high dose rate (UHDR) (>= 40 Gy/s) irradiatio...
The Oriatron eRT6 is an experimental high dose-per-pulse linear accelerator (linac) which was design...
International audienceMost anticancer radiation therapy facilities are based on linear electron acce...
Purpose: The electron linac ElectronFlash installed at Institut Curie (Orsay, France) is entirely de...
FLASH radiation therapy (FLASH-RT), delivered with ultrahigh dose rate (UHDR), may allow patients to...
We describe a multicenter cross validation of ultra-high dose rate (UHDR) (>= 40 Gy/s) irradiatio...
We have performed dosimetry studies using electron beams with energies up to 50 MeV, which exceed cu...
FLASH radiation therapy (FLASH-RT) reference dosimetry to obtain traceability, repeatability and sta...
We have performed dosimetry studies using electron beams with energies up to 50 MeV, which exceed cu...
We have performed dosimetry studies using electron beams with energies up to 50 MeV, which exceed cu...
Abstract Purpose: The Oriatron eRT6 is a linear accelerator (linac) used in FLASH preclinical studie...
Abstract Purpose: The Oriatron eRT6 is a linear accelerator (linac) used in FLASH preclinical studie...
High dose-rate radiotherapy, known as FLASH, has been shown to increase the differential response be...
High dose-rate radiotherapy, known as FLASH, has been shown to increase the differential response be...
As radiotherapy using ultra-high dose rates has gained new interest, the dosimetric challenges arisi...